Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Pfizer (PFE) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDrug Manufacturers - GeneralPFE

Closing price · Nov 19, 2026 $27.64 -1.5% on the day · +16.8% over 12 months 52-week range $23.20 – $30.35
Get PFE alerts
Open-market purchases3 insiders$3.0M · last 12 months
Insiders selling1last 12 months
Reported sales$135K0 of 2 recent sales pre-planned (10b5-1)
In 15 seconds

Insiders put their own money in: $3.0M of open-market buys against $135K of sales. See how similar setups did below.

Past insider buys here: 3 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Strong buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase Albert Bourla, CEO, Chair bought 38,000 shares at $26.34 ($1.0M).

Trade date
Aug 12, 2026
Disclosed to the SEC
Aug 12, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All PFE insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

PFE insider transactions (Form 4)

Open-market purchases and sales. 28 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Aug 12SEC Albert BourlaCEO, ChairFirst buy Buy 38,000429,173 held (+10%) $26.34 $1.0M +5.0% —
Aug 6SEC Jennifer B. DamicoSvp & Controller Sell 3,27828,611 held (−10%) $25.40 $83K +8.8% —
Aug 5SEC Ronald E. BlaylockDirectorStake +142% Buy 39,23166,938 held (+142%) $25.46 $999K +8.6% —
Aug 5SEC Mortimer J. BuckleyDirectorFirst buyNew positionPast buys 0/2 beat S&P Buy 37,632new position $25.52 $960K +8.3% 50
Jun 10SEC Jennifer B. DamicoSvp & Controller Sell 2,00031,397 held (−6%) $25.70 $51K +7.6% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for PFE's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with PFE in the Research Lab

Pre-set to PFE's latest insider buy of $10K or more (Aug 12, 2026: Albert Bourla, Mortimer J. Buckley, Ronald E. Blaylock, $3.0M). Tap to change anything.

All tools →

Share price and insider trades

PFE closeInsider buyInsider sale
2225283032DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-03EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04EEarnings release filed 2026-11-03Sold $51,400 on 2026-06-09 · Jennifer B. DamicoSold $83,261 on 2026-08-05 · Jennifer B. DamicoBought $1,000,920 on 2026-08-12 · Albert BourlaBought $1,959,190 on 2026-08-05 · Mortimer J. Buckley, Ronald E. Blaylock
Bought, 12 months$3.0M
Sold, 12 months$135K
Insiders buying3
Insiders selling1

Pfizer insider trading at a glance (Nov 20, 2026): in the past 12 months, 3 insiders bought $3.0M and 1 sold $135K of PFE stock on the open market, including a cluster buy that began Aug 5, 2026; P/E 41.3 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

PFE insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $51K sold (1 trades)Q2 2026Q3 2026: $3.0M bought (3 trades)$3.0MQ3 2026: $83K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$3.0M3$83K1
Q2 2026—0$51K1

Valuation, profit and volume

P/E (trailing)41.3Sector median 25.0
Market value$164.66BDrug Manufacturers - General
Profit margin6.3%Revenue growth -0.4%
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit+$215KOn all tracked purchases +7.3%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 3 Pfizer insiders reported open-market purchases totaling $3.0M, while 1 insider reported sales totaling $135K. The most recent cluster buy began on Aug 5, 2026, when 3 insiders bought a combined $3.0M. Among insiders with enough purchase history to measure, Mortimer J. Buckley (Director) has the highest Insider Score at 50. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

PFE earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 3, 2026 +3.7% None +0.4%S&P +2.0% pending
Aug 4, 2026 +1.7% None +3.1%S&P +1.6% +10.2%
May 5, 2026 -4.6% None +0.9%S&P +2.2% -0.2%
Feb 3, 2026 +5.7% None +0.5%S&P -1.3% +1.0%
Nov 4, 2025 +0.6% None -0.2%S&P -0.8% +7.6%
Aug 5, 2025 -2.2% None +1.7%S&P +0.3% +4.0%
Apr 29, 2025 +5.2% None +5.9%S&P +0.7% -1.9%
Feb 4, 2025 +1.3% None +0.9%S&P +1.1% +1.1%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

PFE news sentiment trend

Weekly headline tone (positive minus negative headlines) over 13 weeks. Green dots mark weeks with insider buying.

Not enough news
Aug 22Sep 12Week of 2026-09-26: 11 headlines, 4 positive, 1 negativeOct 3Oct 24Nov 14
Last 30 days: 0 headlines, 0 positive, 0 negative

Tone is scored from headline wording only. It describes the news, not where the stock is going.

PFE short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 38% of volume sold short2026-08-27: 38% of volume sold short2026-08-28: 35% of volume sold short2026-08-31: 32% of volume sold short2026-09-01: 39% of volume sold short2026-09-02: 47% of volume sold short2026-09-03: 43% of volume sold short2026-09-04: 44% of volume sold short2026-09-08: 51% of volume sold short2026-09-09: 46% of volume sold short2026-09-10: 49% of volume sold short2026-09-11: 51% of volume sold short2026-09-14: 45% of volume sold short2026-09-15: 29% of volume sold short2026-09-16: 39% of volume sold short2026-09-17: 47% of volume sold short2026-09-18: 46% of volume sold short2026-09-21: 36% of volume sold short2026-09-22: 46% of volume sold short2026-09-23: 42% of volume sold short2026-09-24: 39% of volume sold short2026-09-25: 44% of volume sold short2026-09-28: 39% of volume sold short2026-09-29: 40% of volume sold short2026-09-30: 55% of volume sold short2026-10-01: 47% of volume sold short2026-10-02: 49% of volume sold short2026-10-05: 55% of volume sold short2026-10-06: 47% of volume sold short2026-10-07: 47% of volume sold short2026-10-08: 46% of volume sold short2026-10-09: 44% of volume sold short2026-10-12: 64% of volume sold short2026-10-13: 56% of volume sold short2026-10-14: 44% of volume sold short2026-10-15: 43% of volume sold short2026-10-16: 37% of volume sold short2026-10-19: 44% of volume sold short2026-10-20: 36% of volume sold short2026-10-21: 44% of volume sold short2026-10-22: 36% of volume sold short2026-10-23: 44% of volume sold short2026-10-26: 61% of volume sold short2026-10-27: 46% of volume sold short2026-10-28: 39% of volume sold short2026-10-29: 37% of volume sold short2026-10-30: 38% of volume sold short2026-11-02: 41% of volume sold short2026-11-03: 36% of volume sold short2026-11-04: 29% of volume sold short2026-11-05: 43% of volume sold short2026-11-06: 37% of volume sold short2026-11-09: 41% of volume sold short2026-11-10: 35% of volume sold short2026-11-11: 39% of volume sold short2026-11-12: 49% of volume sold short2026-11-13: 34% of volume sold short2026-11-16: 40% of volume sold short2026-11-17: 29% of volume sold short2026-11-18: 28% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 28%20-day average: 39%Prior 2 months: 44%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded PFE

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Michael A. RulliHouse · R-OH Sold $1,001 - $15,000 Nov 26, 2024Aug 7, 2026 +21.0%
Thomas H TubervilleSenate Sold $15,001 - $50,000 May 3, 2024Aug 5, 2026 +17.2%
Alan ArmstrongSenate Sold $50,001 - $100,000 Mar 24, 2026Jul 21, 2026 +6.1%
Thomas H TubervilleSenate Sold $15,001 - $50,000 Jun 8, 2026Jul 16, 2026 +9.8%
Gilbert Ray Cisneros, Jr.House · D-CA Sold $1,001 - $15,000 Mar 13, 2026Apr 7, 2026 +7.6%
Gilbert Ray Cisneros, Jr.House · D-CA Bought $1,001 - $15,000 Feb 10, 2026Mar 9, 2026 +3.6%
J. French HillHouse · R-AR Sold $100,001 - $250,000 Dec 31, 2025Jan 23, 2026 +16.8%
Julia LetlowHouse · R-LA Bought $1,001 - $15,000 Jun 17, 2025Jan 13, 2026 +25.4%
Gilbert Ray Cisneros, Jr.House · D-CA Sold $1,001 - $15,000 Dec 19, 2025Jan 12, 2026 +15.4%
Gilbert Ray Cisneros, Jr.House · D-CA Bought $1,001 - $15,000 Nov 18, 2025Dec 15, 2025 +14.2%
Lisa C. McClainHouse · R-MI Sold $1,001 - $15,000 Aug 4, 2025Sep 12, 2025 +25.7%

PFE stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

What happened after PFE insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
Aug 12, 2026Albert BourlaCEO, Chair$1.0M +7.3%+7.8% vs S&P+5.4%+6.4% vs S&P+11.6%+14.3% vs S&P
Aug 5, 2026Mortimer J. BuckleyDirector$960K +1.9%+1.6% vs S&P+10.2%+10.2% vs S&P+14.6%+16.3% vs S&P
Aug 5, 2026Ronald E. BlaylockDirector$999K +1.9%+1.6% vs S&P+10.2%+10.2% vs S&P+14.6%+16.3% vs S&P

Insiders at Pfizer

InsiderBoughtSoldLast filingPast buys beat S&PScore
Albert BourlaCEO, Chair $1.0M — Aug 12, 2026 — —
Ronald E. BlaylockDirector $999K — Aug 5, 2026 — —
Mortimer J. BuckleyDirector $960K — Aug 5, 2026 0 of 2 50
Jennifer B. DamicoSvp & Controller — $135K Aug 6, 2026 — —
Douglas M. LanklerPresident — — Feb 27, 2026 — —
Lidia FonsecaPresident — — Feb 27, 2026 — —
Payal SahniPresident — — Feb 27, 2026 — —
Michael McDermottPresident — — Feb 27, 2026 — —
Christoffel BoshoffPresident — — Feb 27, 2026 — —

Board links: companies that share insiders with PFE

Directors and executives who filed Form 4s for PFE and another company in the last 12 months.

See the map →
  • BABoeing Mortimer J. Buckley Director here · Director at BA · latest filing Nov 3, 2026
  • MDTMedtronic Lidia Fonseca President here · Director at MDT · latest filing Apr 29, 2026
  • WRBW. R. Berkley Ronald E. Blaylock Director here · Director at WRB · latest filing Aug 5, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

PFE stock: common questions

Are Pfizer insiders buying PFE stock?

In the past 12 months, 3 insiders reported open-market purchases of PFE worth $3.0M. The latest was CEO, Chair Albert Bourla bought $1.0M of PFE at $26.34 — first open-market purchase in our records.

Are Pfizer insiders selling PFE stock?

1 insider reported sales worth $135K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is PFE's P/E ratio?

PFE trades at about 41.3 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is PFE's 52-week range?

Over the past year PFE has traded between $23.20 and $30.35. It last closed at $27.64 on Nov 19, 2026.